178 related articles for article (PubMed ID: 14654233)
21. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.
Frigolet ME; Thomas G; Beard K; Lu H; Liu L; Fantus IG
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E321-E334. PubMed ID: 28679626
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
23. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
24. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular and renal effect of CNAAC: An innovatively designed natriuretic peptide.
Zhang S; Geng X; Zhao L; Li J; Tian F; Wang Y; Fan R; Feng N; Liu J; Cheng L; Pei J
Eur J Pharmacol; 2015 Aug; 761():180-8. PubMed ID: 25979857
[TBL] [Abstract][Full Text] [Related]
26. Natriuretic peptide activation of extracellular regulated kinase 1/2 (ERK1/2) pathway by particulate guanylyl cyclases in GH3 somatolactotropes.
Jonas KC; Melrose T; Thompson IR; Baxter GF; Lipscomb VJ; Niessen SJ; Lawson C; McArdle CA; Roberson MS; McGonnell IM; Wheeler-Jones CP; Fowkes RC
Cell Tissue Res; 2017 Sep; 369(3):567-578. PubMed ID: 28451751
[TBL] [Abstract][Full Text] [Related]
27. Expression and functional roles of guanylate cyclase isoforms in BRIN-BD11 β-cells.
Russell MA; Morgan NG
Islets; 2010; 2(6):374-82. PubMed ID: 21099339
[TBL] [Abstract][Full Text] [Related]
28. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
Suda M; Tanaka K; Yasoda A; Komatsu Y; Chusho H; Miura M; Tamura N; Ogawa Y; Nakao K
J Bone Miner Metab; 2002; 20(3):136-41. PubMed ID: 11984695
[TBL] [Abstract][Full Text] [Related]
29. 17 beta-estradiol modifies nitric oxide-sensitive guanylyl cyclase expression and down-regulates its activity in rat anterior pituitary gland.
Cabilla JP; Díaz Mdel C; Machiavelli LI; Poliandri AH; Quinteros FA; Lasaga M; Duvilanski BH
Endocrinology; 2006 Sep; 147(9):4311-8. PubMed ID: 16740976
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
Marsden PA; Ballermann BJ
J Exp Med; 1990 Dec; 172(6):1843-52. PubMed ID: 1979590
[TBL] [Abstract][Full Text] [Related]
31. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G.
Wu BN; Chen CW; Liou SF; Yeh JL; Chung HH; Chen IJ
Mol Pharmacol; 2006 Sep; 70(3):977-85. PubMed ID: 16754782
[TBL] [Abstract][Full Text] [Related]
33. Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?
Xiao S; Li Q; Hu L; Yu Z; Yang J; Chang Q; Chen Z; Hu G
Mini Rev Med Chem; 2019; 19(18):1544-1557. PubMed ID: 31362687
[TBL] [Abstract][Full Text] [Related]
34. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
35. Molecular and biochemical characterization of a CNP-sensitive guanylyl cyclase in bovine tracheal smooth muscle.
Borges A; de Villarroel SS; Winand NJ; de Bécemberg IL; Alfonzo MJ; de Alfonzo RG
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):98-103. PubMed ID: 11472981
[TBL] [Abstract][Full Text] [Related]
36. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Sep; 79(1):66-70. PubMed ID: 9735242
[TBL] [Abstract][Full Text] [Related]
37. Chronic hypoxic decreases in soluble guanylate cyclase protein and enzyme activity are age dependent in fetal and adult ovine carotid arteries.
Williams JM; White CR; Chang MM; Injeti ER; Zhang L; Pearce WJ
J Appl Physiol (1985); 2006 Jun; 100(6):1857-66. PubMed ID: 16469937
[TBL] [Abstract][Full Text] [Related]
38. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
39. What is next in nitric oxide research? From cardiovascular system to cancer biology.
Bian K; Murad F
Nitric Oxide; 2014 Dec; 43():3-7. PubMed ID: 25153032
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
Filippov G; Bloch DB; Bloch KD
J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
